Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies

Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR). CAR-T cell therapies have advanced the furthest, with recent approvals of two treatments by the Food and Drug Administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombard-Banek, Camille, Schiel, John E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144572/
https://www.ncbi.nlm.nih.gov/pubmed/32204371
http://dx.doi.org/10.3390/molecules25061396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144572/
https://www.ncbi.nlm.nih.gov/pubmed/32204371
http://dx.doi.org/10.3390/molecules25061396

Ejemplares similares